EconPapers    
Economics at your fingertips  
 

The capicua-ataxin-1-like complex regulates Notch-driven marginal zone B cell development and sepsis progression

Jong Seok Park, Minjung Kang, Han Bit Kim, Hyebeen Hong, Jongeun Lee, Youngkwon Song, Yunjung Hur, Soeun Kim, Tae-Kyung Kim and Yoontae Lee ()
Additional contact information
Jong Seok Park: Pohang University of Science and Technology (POSTECH)
Minjung Kang: Pohang University of Science and Technology (POSTECH)
Han Bit Kim: Pohang University of Science and Technology (POSTECH)
Hyebeen Hong: Pohang University of Science and Technology (POSTECH)
Jongeun Lee: Pohang University of Science and Technology (POSTECH)
Youngkwon Song: Pohang University of Science and Technology (POSTECH)
Yunjung Hur: Pohang University of Science and Technology (POSTECH)
Soeun Kim: Pohang University of Science and Technology (POSTECH)
Tae-Kyung Kim: Pohang University of Science and Technology (POSTECH)
Yoontae Lee: Pohang University of Science and Technology (POSTECH)

Nature Communications, 2024, vol. 15, issue 1, 1-15

Abstract: Abstract Follicular B (FOB) and marginal zone B (MZB) cells are pivotal in humoral immune responses against pathogenic infections. MZB cells can exacerbate endotoxic shock via interleukin-6 secretion. Here we show that the transcriptional repressor capicua (CIC) and its binding partner, ataxin-1-like (ATXN1L), play important roles in FOB and MZB cell development. CIC deficiency reduces the size of both FOB and MZB cell populations, whereas ATXN1L deficiency specifically affects MZB cells. B cell receptor signaling is impaired only in Cic-deficient FOB cells, whereas Notch signaling is disrupted in both Cic-deficient and Atxn1l-deficient MZB cells. Mechanistically, ETV4 de-repression leads to inhibition of Notch1 and Notch2 transcription, thereby inhibiting MZB cell development in B cell-specific Cic-deficient (Cicf/f;Cd19-Cre) and Atxn1l-deficient (Atxn1lf/f;Cd19-Cre) mice. In Cicf/f;Cd19-Cre and Atxn1lf/f; Cd19-Cre mice, humoral immune responses and lipopolysaccharide-induced sepsis progression are attenuated but are restored upon Etv4-deletion. These findings highlight the importance of the CIC-ATXN1L complex in MZB cell development and may provide proof of principle for therapeutic targeting in sepsis.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-024-54803-z Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-54803-z

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-024-54803-z

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-54803-z